Elizabeth Ofili to Middle Aged
This is a "connection" page, showing publications Elizabeth Ofili has written about Middle Aged.
Connection Strength
0.885
-
Pemu P, Josiah Willock R, Alema-Mensa E, Rollins L, Brown M, Saint Clair B, Olorundare E, McCaslin A, Henry Akintobi T, Quarshie A, Ofili E. Achieving Health Equity with e-Healthystrides?: Patient Perspectives of a Consumer Health Information Technology Application. Ethn Dis. 2019; 29(Suppl 2):393-404.
Score: 0.066
-
Rollins L, Sy A, Crowell N, Rivers D, Miller A, Cooper P, Teague D, Jackson C, Henry Akintobi T, Ofili E. Learning and Action in Community Health: Using the Health Belief Model to Assess and Educate African American Community Residents about Participation in Clinical Research. Int J Environ Res Public Health. 2018 08 28; 15(9).
Score: 0.062
-
Ofili EO, Pemu PE, Quarshie A, Mensah EA, Rollins L, Ojutalayo F, McCaslin A, Clair BS. DEMOCRATIZING DISCOVERY HEALTH WITH N=Me. Trans Am Clin Climatol Assoc. 2018; 129:215-234.
Score: 0.060
-
Ofili E, Anand I, Williams RA, Akinboboye O, Xu L, Puckrein G. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure. Adv Ther. 2017 08; 34(8):1976-1988.
Score: 0.058
-
Ofili EO, Zappe DH, Purkayastha D, Samuel R, Sowers JR. Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients. Am J Ther. 2013 Jan; 20(1):2-12.
Score: 0.042
-
Ofili EO, Oparil S, Giles T, Pitt B, Purkayastha D, Hilkert R, Samuel R, Sowers JR. Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups. J Am Soc Hypertens. 2011 Jul-Aug; 5(4):249-58.
Score: 0.037
-
Pemu PE, Quarshie AQ, Josiah-Willock R, Ojutalayo FO, Alema-Mensah E, Ofili EO. Socio-demographic psychosocial and clinical characteristics of participants in e-HealthyStrides?: an interactive ehealth program to improve diabetes self-management skills. J Health Care Poor Underserved. 2011; 22(4 Suppl):146-64.
Score: 0.037
-
Lapu-Bula R, Onwuanyi A, Bielo MV, Deffer O, Quarshie A, Alema-Mensah E, Cross JA, Oduwole A, Ofili E. Risk factors for acute non-ST-segment elevation myocardial infarction in a population sample of predominantly African American patients with chest pain and normal coronary arteries. Ethn Dis. 2011; 21(4):421-8.
Score: 0.037
-
Ofili EO, Cable G, Neutel JM, Saunders E. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial. J Womens Health (Larchmt). 2008 Jul-Aug; 17(6):931-8.
Score: 0.031
-
Pemu PI, Ofili E. Hypertension in women--part II. J Clin Hypertens (Greenwich). 2008 Jun; 10(6):497-500.
Score: 0.031
-
Egan BM, Lackland DT, Igho-Pemu P, Hendrix KH, Basile J, Rehman SU, Okonofua EC, Quarshie A, Oduwole A, Onwuanyi A, Reed J, Obialo C, Ofili EO. Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):879-86.
Score: 0.028
-
Onwuanyi AE, Abe O, Quarshie A, Al-Mahmoud A, Lapu-Bula R, Francis CK, Ofili E. Comparative frequency of angiographic coronary artery disease in African Americans and Hispanics. Ethn Dis. 2006; 16(1):58-63.
Score: 0.026
-
Ofili E, Pemu PI, Gulaya V, Bula RL, Lapu-Bula R, Lankford B, Oduwole A, Anderson D. Targeting healthcare disparities: an integrated model to improve treatment rates of dyslipidemia in African American patients. Curr Atheroscler Rep. 2005 Jul; 7(4):249-50.
Score: 0.025
-
Lapu-Bula R, Quarshie A, Lyn D, Oduwole A, Pack C, Morgan J, Nkemdiche S, Igho-Pemu P, Onwuanyi A, Li R, Ofili E. The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure. J Natl Med Assoc. 2005 Feb; 97(2):197-205.
Score: 0.024
-
Igho-Pemu P, Quarshie A, Oduwole A, Lapu-Bula R, Mayberry R, Obialo C, Gibbons GH, Ofili E. Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education. Ethn Dis. 2005; 15(4 Suppl 5):S5-120-3.
Score: 0.024
-
Li R, Lyn D, Lapu-Bula R, Oduwole A, Igho-Pemu P, Lankford B, Morgan J, Nkemdechi S, Liu G, Pack C, Silvestrov N, von Deutsch DA, Song Q, Abukhalaf IK, Ofili E. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am J Hypertens. 2004 Jul; 17(7):560-7.
Score: 0.023
-
Ofili E. Ethnic disparities in cardiovascular health. Ethn Dis. 2001; 11(4):838-40.
Score: 0.018
-
Banigbe BF, Itanyi IU, Ofili EO, Ogidi AG, Patel D, Ezeanolue EE. High prevalence of undiagnosed hypertension among men in North Central Nigeria: Results from the Healthy Beginning Initiative. PLoS One. 2020; 15(11):e0242870.
Score: 0.018
-
Norris KC, McCreath HE, Hueffer K, Aley SB, Chavira G, Christie CA, Crespi CM, Crespo C, D'Amour G, Eagan K, Echegoyen LE, Feig A, Foroozesh M, Guerrero LR, Johanson K, Kamangar F, Kingsford L, LaCourse W, Maccalla NM, M?rquez-Maga?a L, Mathur A, Maton K, Mehravaran S, Morales DX, Nakazono T, Ofili E, Okuyemi K, Ott L, Parangan-Smith A, Pfund C, Purnell D, Reynolds A, Rous PJ, Saetermoe C, Snyder K, Vishwanatha JK, Wagler A, Wallace SP, Seeman T. Baseline Characteristics of the 2015-2019 First Year Student Cohorts of the NIH Building Infrastructure Leading to Diversity (BUILD) Program. Ethn Dis. 2020; 30(4):681-692.
Score: 0.018
-
Ofili EO, Mayberry R, Alema-Mensah E, Saleem S, Hamirani K, Jones C, Salih S, Lankford B, Oduwole A, Igho-Pemu P. Gender differences and practice implications of risk factors for frequent hospitalization for heart failure in an urban center serving predominantly African-American patients. Am J Cardiol. 1999 May 01; 83(9):1350-5.
Score: 0.016
-
Ofili EO, Cohen JD, St Vrain JA, Pearson A, Martin TJ, Uy ND, Castello R, Labovitz AJ. Effect of treatment of isolated systolic hypertension on left ventricular mass. JAMA. 1998 Mar 11; 279(10):778-80.
Score: 0.015
-
Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015 May 19; 131(20):1763-71.
Score: 0.012
-
Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, D?vila-Rom?n VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18; 310(23):2533-43.
Score: 0.011
-
Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013 Mar 27; 309(12):1268-77.
Score: 0.011
-
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012 Dec 13; 367(24):2296-304.
Score: 0.010
-
Pemu PE, Anderson L, Gee BE, Ofili EO, Ghosh S. Early alterations of the immune transcriptome in cultured progenitor cells from obese African-American women. Obesity (Silver Spring). 2012 Jul; 20(7):1481-90.
Score: 0.010
-
Giles TD, Oparil S, Ofili EO, Pitt B, Purkayastha D, Hilkert R, Samuel R, Sowers JR. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy. Blood Press Monit. 2011 Apr; 16(2):87-95.
Score: 0.009
-
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O'Connor CM. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 03; 364(9):797-805.
Score: 0.009
-
Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
Score: 0.009
-
Brennan T, Spettell C, Villagra V, Ofili E, McMahill-Walraven C, Lowy EJ, Daniels P, Quarshie A, Mayberry R. Disease management to promote blood pressure control among African Americans. Popul Health Manag. 2010 Apr; 13(2):65-72.
Score: 0.009
-
McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Venkitachalam L, Ofili E, Yancy C, Feldman AM, Ghali JK, Taylor AL, Cohn JN, Worcel M. Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. J Card Fail. 2009 Apr; 15(3):191-8.
Score: 0.008
-
Fontaine JM, Ofili EO, Adenaike MB, VanDecker W, Haywood LJ. Clinical assessment of the risk for sudden cardiac death in patients with sickle cell anemia. J Natl Med Assoc. 2008 Apr; 100(4):360-8.
Score: 0.008
-
Cushman WC, Neutel JM, Saunders E, Bakris GL, Ferdinand KC, Ofili EO, Sowers JR, Madder R, Weber MA. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy. Am J Geriatr Cardiol. 2008 Jan-Feb; 17(1):27-36.
Score: 0.007
-
Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. Circulation. 2007 Apr 03; 115(13):1747-53.
Score: 0.007
-
Weber MA, Bakris GL, Dahl?f B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Weir M, Kjeldsen S, Massie B, Nesbitt S, Ofili E, Jamerson K. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press. 2007; 16(1):13-9.
Score: 0.007
-
Taylor AL, Lindenfeld J, Ziesche S, Walsh MN, Mitchell JE, Adams K, Tam SW, Ofili E, Sabolinski ML, Worcel M, Cohn JN. Outcomes by gender in the African-American Heart Failure Trial. J Am Coll Cardiol. 2006 Dec 05; 48(11):2263-7.
Score: 0.007
-
Sowers JR, Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC, Ofili EO, Weber MA. Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes. J Clin Hypertens (Greenwich). 2006 Jul; 8(7):470-80.
Score: 0.007
-
Obialo CI, Ofili EO, Quarshie A, Martin PC. Ultralate referral and presentation for renal replacement therapy: socioeconomic implications. Am J Kidney Dis. 2005 Nov; 46(5):881-6.
Score: 0.006
-
Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC, Ofili EO, Sowers JR, Weber MA. The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial. J Clin Hypertens (Greenwich). 2005 Oct; 7(10):578-86.
Score: 0.006
-
Akomolafe A, Quarshie A, Jackson P, Thomas J, Deffer O, Oduwole A, Onwuanyi A, Lapu-Bula R, Strayhorn G, Ofili E, Mayberry R. The prevalence of cognitive impairment among African-American patients with congestive heart failure. J Natl Med Assoc. 2005 May; 97(5):689-94.
Score: 0.006
-
Smith SC, Clark LT, Cooper RS, Daniels SR, Kumanyika SK, Ofili E, Quinones MA, Sanchez EJ, Saunders E, Tiukinhoy SD. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation. 2005 Mar 15; 111(10):e134-9.
Score: 0.006
-
Obialo CI, Sharda S, Goyal S, Ofili EO, Oduwole A, Gray N. Ability of troponin T to predict angiographic coronary artery disease in patients with chronic kidney disease. Am J Cardiol. 2004 Sep 15; 94(6):834-6.
Score: 0.006
-
Obialo CI, Ofili EO, Mirza T. Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease. Am J Cardiol. 2002 Sep 15; 90(6):663-5.
Score: 0.005
-
Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, Papademetriou V, Clark LT, Ofili EO, Randall OS, Oikarinen L, Viitasalo M, Toivonen L, Julius S, Dahl?f B, Devereux RB. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens. 2002 Aug; 15(8):663-71.
Score: 0.005
-
Franciosa JA, Taylor AL, Cohn JN, Yancy CW, Ziesche S, Olukotun A, Ofili E, Ferdinand K, Loscalzo J, Worcel M. African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. J Card Fail. 2002 Jun; 8(3):128-35.
Score: 0.005